Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meritage Pharma Inc.

Division of Takeda Pharmaceutical Co. Ltd.
www.meritagepharma.com

Latest From Meritage Pharma Inc.

Shire/Actelion rumors highlight M&A buzz in orphan space

Reports of a £12.4bn ($18.9bn) preliminary approach sent Shire's share price down by 2.75% to £53.05 on the London Stock Exchange on 8 June, while Actelion's stock rose nearly 10% to an all-time high of CHF144.50 on the Swiss exchange, pushing its market capitalization up to CHF16.5bn ($17.5bn).

Gastrointestinal Cardiovascular

Shire acquires Meritage for potential $245m

Shire is continuing its 2015 M&A shopping spree by acquiring Meritage Pharma for $70m upfront in order to boost its late-stage rare disease pipeline.

Gastrointestinal Orthopedics

4Q PREVIEW: 'One Shire' pipeline news and ViroPharma update expected

Though there have been bumps in the road for Shire recently – in the form of a Phase III failure for Vyvanse (lisdexamfetamine dimesylate) in major depressive disorder and the disposal of diabetic foot ulcer product Dermagraft for no money upfront – the firm has seen its stock continue on a steady upsurge.

Dermatology Infectious Diseases

Clinical Data In 2014 Could Trigger Private Biotech Financings

Despite difficulties financing late-stage trials, several private companies are expecting Phase II and III data that should help shape public investor sentiment this year. Familiar compounds in new guises lead the way.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Elaine M Phillips, PhD, Pres. & CEO
    Adam K Simpson, CBO
    Malcom R Hill, CSO
  • Contact Info
  • Meritage Pharma Inc.
    Phone: (858) 436-1660
    12481 High Bluff Dr., Ste. 160
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register